YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Global bond markets are under pressure as government borrowing costs climb to levels not seen in decades, which has pushed many growth stories out of favour. That kind of rate shock can leave solid Australian tech businesses trading at pri…
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Bioventus (BVS) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to…
A rate hike is almost inevitable if inflation remains high, Federal Reserve officials believe, according to the minutes of the Fed's latest policy meeting. A third of the committee members voted to hike interest rates last month, but the c…
Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Rob ClaypooleSenior Vice President and Chief Financial Officer - Mark SingletonInvestor Relations - Dave…
Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Rob Claypoole Senior Vice President and Chief Financial Officer - Mark Singleton Investor Relations - Dav…
(RTTNews) - The following biotech stocks reached a 52-week high on August 5, 2026, primarily driven by positive quarterly reports. Bioventus Inc. (BVS) Bioventus is a medical device company that focuses on technology for pain management an…
Wall Street expects a year-over-year increase in earnings on higher revenues when Bioventus (BVS) reports results for the quarter ended June 2026. While this widely-known consensus outlook is important in gauging the company's earnings pic…
(RTTNews) - The following biotech stocks reached a 52-week high on July 28, 2026, driven by key catalysts including positive quarterly results. Incyte Corporation (INCY) Incyte is a biopharmaceutical company primarily engaged in discoverin…
(RTTNews) - The following biotech stocks reached 52-week highs on July 16, 2026, resulting due to anticipated quarterly report releases or an upcoming conference participation. CareDx Inc. (CDNA) CareDx is a precision medicine company spec…
For Immediate Release Chicago, IL – July 7, 2026 – Stocks in this week's article are First Advantage Corp. FA, Bioventus Inc. BVS and Ooma, Inc. OOMA. 3 Top Breakout Stocks to Snap Up for Big Upside in July 2026 As July begins, investors c…
As July begins, investors can enhance returns by taking a more active approach to stock selection, identifying potential breakout opportunities within well-defined price ranges. Under this strategy, a stock should be sold if it falls below…
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is BrightSpring Health Services, Inc. (BTSG) one of those stocks right now? Let's take a closer look at…
Key Points Interested in Bioventus Inc.? Here are five stocks we like better. Bioventus said its financial profile has improved materially, with EBITDA margins rising above 20% in 2025, free cash flow turning positive, and leverage falling…
Quick Read Consumer sentiment has collapsed to levels unseen in years, pushing investors toward defensive healthcare and consumer staples names with pricing power and recurring revenue models. The analyst who called NVIDIA in 2010 just nam…
The Australian share market is experiencing a downturn following the latest budget announcement and external pressures from the U.S., where rising inflation has unsettled investors. Despite these challenges, certain sectors continue to off…
Bioventus Inc. Q1 2026 Earnings Call Summary - Moby Strategic Execution and Performance Drivers Performance was driven by above-market growth in the core portfolio and disciplined resource allocation across geographies and channels. The co…
Bioventus logo Bioventus (NASDAQ:BVS) reported first-quarter 2026 results that management said put the company “off to a strong start” as it increased investment in several growth drivers while still expanding profitability and cash genera…
Bioventus (BVS) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.08 per share a year ago. These figures are adjusted for non-recurring items. This…
Q1 reported revenue of $132.1 million increased 7%First quarter GAAP earnings of $0.04 per diluted share compared to the prior-year period loss of $0.04 per diluted shareNon-GAAP earnings* of $0.15 per diluted share compared to $0.08 per d…
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly l…
DURHAM, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of…
Bioventus (BVS) shares rallied 6.6% in the last trading session to close at $10.56. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 10.2% g…
The Australian market is experiencing a surge with the ASX 200 futures showing a significant hike, buoyed by renewed global optimism following geopolitical developments. In such dynamic conditions, investors often look beyond established g…
Bioventus logo Key Points Solid Q4 and record cash flow: Revenue was $158M (+3% reported, +10% organic), adjusted EBITDA was $37M (+30%) with a 23% margin, and operating cash flow reached a quarterly record of $38M (full-year cash from ops…
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Alaska Air Group, Inc. (Symbol: ALK), where a total volume of 20,296 contracts has been traded thus far today, a contract…
Bioventus Inc. Q4 2025 Earnings Call Summary - Moby Strategic Performance and Transformation Drivers Management characterizes the company as having completed a three-year transformation, shifting from foundational stabilization to an 'exci…
Image source: The Motley Fool. DATE Thursday, March 5, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Robert E. Claypoole Chief Financial Officer — Mark L. Singleton Need a quote from a Motley Fool analyst? Email pr@fool.…
In the last week, the Australian market has been flat, but over the past 12 months, it has risen by 4.0%, with earnings forecasted to grow by 12% annually. In light of these conditions, identifying stocks that combine affordability with gr…
Bioventus, Inc. DURHAM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Chief Executive Officer, will present at the 44th Annual J…
As we enter January 2026, the Asian markets are capturing investor attention amid a backdrop of mixed global economic signals and modest gains in key indices. While the U.S. economy shows robust growth and China's market maintains steady p…
The Australian stock market is showing modest gains, buoyed by a late Christmas rally in the U.S., with precious metals and the Australian dollar also enjoying strong performances. In this context, investors might find value in exploring p…
DURHAM, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Bioventus President and Chief Executive Officer, will present at the Piper…
As Australian shares are poised for a potential upswing, driven by positive sentiments from the U.S. market and upcoming domestic economic data releases, investors are keeping a keen eye on various market segments. Penny stocks, often asso…
The Australian market is experiencing a cautious phase, with traders pausing to assess recent volatility and upcoming significant earnings reports. For investors willing to explore beyond well-known stocks, penny stocks—typically represent…
As the Australian market experiences a turbulent period, with tech indices notably down and every sector in the red, investors are searching for opportunities amidst the volatility. Penny stocks, though an outdated term, still represent a…
The Australian market is experiencing turbulence, with the ASX 200 futures indicating a significant drop following the recent end of the U.S. government shutdown and ongoing economic uncertainties. Despite this volatility, penny stocks con…